AR065365A1 - Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo - Google Patents

Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo

Info

Publication number
AR065365A1
AR065365A1 ARP080100649A ARP080100649A AR065365A1 AR 065365 A1 AR065365 A1 AR 065365A1 AR P080100649 A ARP080100649 A AR P080100649A AR P080100649 A ARP080100649 A AR P080100649A AR 065365 A1 AR065365 A1 AR 065365A1
Authority
AR
Argentina
Prior art keywords
compounds
pharmaceutical
plants
synthesis
vitiligo
Prior art date
Application number
ARP080100649A
Other languages
English (en)
Spanish (es)
Inventor
Queiroz Emerson Ferreira
Original Assignee
Siaulys De Campos Lara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siaulys De Campos Lara filed Critical Siaulys De Campos Lara
Publication of AR065365A1 publication Critical patent/AR065365A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
ARP080100649A 2007-02-15 2008-02-15 Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo AR065365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700767A BRPI0700767B8 (pt) 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Publications (1)

Publication Number Publication Date
AR065365A1 true AR065365A1 (es) 2009-06-03

Family

ID=39689569

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100649A AR065365A1 (es) 2007-02-15 2008-02-15 Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo

Country Status (16)

Country Link
US (6) US20100028400A1 (fr)
EP (1) EP2117533B1 (fr)
JP (1) JP5443174B2 (fr)
AR (1) AR065365A1 (fr)
BR (1) BRPI0700767B8 (fr)
CA (1) CA2678407C (fr)
CL (1) CL2008000484A1 (fr)
CO (1) CO6220946A2 (fr)
DK (1) DK2117533T3 (fr)
ES (1) ES2531759T3 (fr)
MX (1) MX2009008799A (fr)
PL (1) PL2117533T3 (fr)
PT (1) PT2117533E (fr)
SI (1) SI2117533T1 (fr)
UY (1) UY30920A1 (fr)
WO (1) WO2008098325A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0700767B8 (pt) * 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
BR102017003318A2 (pt) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5174253A (ja) 1974-12-24 1976-06-28 Sharp Kk Teidenatsusochi
JP3627068B2 (ja) * 1995-03-29 2005-03-09 日本メナード化粧品株式会社 育毛剤
IT1317732B1 (it) * 2000-01-20 2003-07-15 Giuliani Spa Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per
EP1145709A1 (fr) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Utilisation de produits naturels pour préparer des compositions cosmétiques
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
FR2848117B1 (fr) 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
BRPI0406343A (pt) * 2004-11-16 2006-08-01 Marcal De Queiroz Paulo fitomedicamento para repigmentação da pele - vitiligo
EP1736167B1 (fr) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Des extraits obtenus à partir des lignées cellulaires des Syringa vulgaris IRB-SV25/B (DMS:16857), leur préparation et utilisation
US7399783B2 (en) * 2005-06-22 2008-07-15 The Quigley Corporation Methods for the treatment of scar tissue
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
BRPI0700767B8 (pt) 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Also Published As

Publication number Publication date
US10813970B2 (en) 2020-10-27
US20130287868A1 (en) 2013-10-31
US10813971B2 (en) 2020-10-27
BRPI0700767A (pt) 2008-09-30
CA2678407A1 (fr) 2008-08-21
US20180071356A1 (en) 2018-03-15
PL2117533T3 (pl) 2015-06-30
JP2010518127A (ja) 2010-05-27
DK2117533T3 (en) 2015-03-09
ES2531759T3 (es) 2015-03-18
CO6220946A2 (es) 2010-11-19
WO2008098325A1 (fr) 2008-08-21
US20190134136A1 (en) 2019-05-09
EP2117533A4 (fr) 2010-08-04
UY30920A1 (es) 2008-09-02
US20180071357A1 (en) 2018-03-15
BRPI0700767B8 (pt) 2021-05-25
BRPI0700767B1 (pt) 2020-09-15
MX2009008799A (es) 2009-10-28
SI2117533T1 (sl) 2015-05-29
PT2117533E (pt) 2015-03-10
US20100028400A1 (en) 2010-02-04
US20220000961A1 (en) 2022-01-06
EP2117533A1 (fr) 2009-11-18
CL2008000484A1 (es) 2008-09-05
JP5443174B2 (ja) 2014-03-19
CA2678407C (fr) 2021-08-31
EP2117533B1 (fr) 2014-12-03

Similar Documents

Publication Publication Date Title
Ahmad et al. Biological activities of Salvadora persica L
TWI718432B (zh) 用於關節健康之組合物及方法
NO20064671L (no) Avlevering av funksjonelle ingredienser
ES2683296T3 (es) Composición a base de flavonoides para uso farmacéutico, nutricional o cosmético con acción antioxidante potenciada
Chan et al. Phytochemistry and pharmacology of three Piper species: An update
Elumalai et al. Phytochemical and pharmacological profile Of Ixora coccinea Linn.
RU2009144535A (ru) Антимикробные и противовоспалительные вещества, выделенные из экстракта лакричника
ES2391211B1 (es) Combinacion sinergica de polifenoles
Divya et al. Wound healing and in vitro antioxidant activities of Croton bonplandianum leaf extract in rats
Sheela et al. Total Phenolics and Flavonoids among The Selected Species of Syzygium, Gaertn.
AR050304A1 (es) Un procedimiento para fabricar te
AR065365A1 (es) Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo
Karpova et al. Flavonoids in adaptation of Begonia grandis Dryander subsp. grandis introduced in West Siberia (Novosibirsk)
Rosamah et al. The potential of Macaranga plants as skincare cosmetic ingredients: A review
Chaguthi et al. An overview on therapeutic potential of Azadirachta indica
FERRER et al. Search of new antimitotics compounds from the Cuban flora
WO2014173635A1 (fr) Composition topique pour la croissance des cheveux
Mohammed Study of some Miswak (Salvadora persica L) components and effect of their aqueous extract on antioxidant
Doudach et al. Cytotoxic & antioxidant activity of various extracts of Corrigiola telephiifolia Pourr
BR122020000045B8 (pt) processo para obtenção de compostos farmacêuticos fitoterápicos a partir uma ou mais partes de plantas do gênero stachytarpheta
BR112012018696A2 (pt) composição farmacêutica com atividade antiobesidade compreendendo uma pré-mistura de orlistat puro e processo de preparação
AR065339A1 (es) Composicion farmaceutica, producto farmaceutico, procesos de obtencion de compuestos farmaceuticos y uso de tales compuestos para el tratamiento de la disfuncion erectil
JP7466884B2 (ja) 正常ヒト歯肉線維芽細胞におけるｉ型コラーゲン産生促進剤
Rosamah et al. Online First
EA200870567A1 (ru) Производные 2-алкокси-3,4,5-тригидроксиалкиламида, их получение, композиции, их содержащие, и применение

Legal Events

Date Code Title Description
FB Suspension of granting procedure